FI77048B - Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner. - Google Patents

Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner.

Info

Publication number
FI77048B
FI77048B FI812295A FI812295A FI77048B FI 77048 B FI77048 B FI 77048B FI 812295 A FI812295 A FI 812295A FI 812295 A FI812295 A FI 812295A FI 77048 B FI77048 B FI 77048B
Authority
FI
Finland
Prior art keywords
preparation
humanproteiner
blodkoagulationsbefraemjande
foerfarande foer
foer framstaellning
Prior art date
Application number
FI812295A
Other languages
English (en)
Other versions
FI77048C (fi
FI812295L (fi
Inventor
Johann Eibl
Otto Schwarz
Fritz Elsinger
Anton Philapitsch
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI812295L publication Critical patent/FI812295L/fi
Application granted granted Critical
Publication of FI77048B publication Critical patent/FI77048B/fi
Publication of FI77048C publication Critical patent/FI77048C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI812295A 1980-07-22 1981-07-22 Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner. FI77048C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT378180 1980-07-22
AT0378180A ATA378180A (de) 1980-07-22 1980-07-22 Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen

Publications (3)

Publication Number Publication Date
FI812295L FI812295L (fi) 1982-01-23
FI77048B true FI77048B (fi) 1988-09-30
FI77048C FI77048C (fi) 1989-01-10

Family

ID=3555339

Family Applications (1)

Application Number Title Priority Date Filing Date
FI812295A FI77048C (fi) 1980-07-22 1981-07-22 Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner.

Country Status (17)

Country Link
US (1) US4395396A (fi)
AR (1) AR227194A1 (fi)
AT (2) ATA378180A (fi)
BE (1) BE889640A (fi)
CH (1) CH646061A5 (fi)
DE (1) DE3127318A1 (fi)
DK (1) DK155500C (fi)
ES (1) ES8203610A1 (fi)
FI (1) FI77048C (fi)
FR (1) FR2487199A1 (fi)
GB (1) GB2080312B (fi)
HU (1) HU188298B (fi)
IT (1) IT1142032B (fi)
LU (1) LU83499A1 (fi)
NL (1) NL190268C (fi)
NO (1) NO157245C (fi)
SE (1) SE460174B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
FR2622108B1 (fr) * 1987-10-23 1990-03-02 Lille Transfusion Sanguine Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
CA2105282C (en) 1991-03-01 2002-09-24 Centeon L.L.C. Preparation of factor ix
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
FR2711371B1 (fr) * 1993-10-18 1995-12-29 Aetsrn Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
DE59712322D1 (de) * 1996-03-20 2005-06-30 Baxter Ag Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
BR9807936A (pt) * 1997-04-08 2000-02-22 Baxter Ag Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT411997B (de) 1999-09-14 2004-08-26 Baxter Ag Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
US7226615B2 (en) 2000-11-07 2007-06-05 Cryolife, Inc. Expandable foam-like biomaterials and methods
RS20050051A (sr) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Farmaceutski aktivni sastojak preparata i medikamenata koji sadrže trombin ili imaju mogućnost stvaranja trombina
AU2003246448A1 (en) * 2002-07-23 2004-02-16 Bio-Products And Bio-Engineering Aktiengesellschaft Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin
US7297336B2 (en) 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492108A1 (de) 1964-05-04 1969-10-02 Rohm & Haas Verfahren zur Entfernung von Viren aus Blut waehrend der Entnahme oder UEbertragung
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4081432A (en) 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them

Also Published As

Publication number Publication date
FI77048C (fi) 1989-01-10
GB2080312B (en) 1983-12-21
HU188298B (en) 1986-03-28
ES504000A0 (es) 1982-04-16
DK318581A (da) 1982-01-23
SE460174B (sv) 1989-09-18
FR2487199B1 (fi) 1984-11-16
AT368883B (de) 1982-11-25
SE8103759L (sv) 1982-01-23
DE3127318C2 (fi) 1988-07-28
CH646061A5 (de) 1984-11-15
ES8203610A1 (es) 1982-04-16
ATA378180A (de) 1982-04-15
NL190268B (nl) 1993-08-02
BE889640A (fr) 1981-11-03
US4395396A (en) 1983-07-26
NO812500L (no) 1982-01-25
LU83499A1 (de) 1981-10-29
GB2080312A (en) 1982-02-03
NO157245B (no) 1987-11-09
DK155500C (da) 1989-08-07
IT1142032B (it) 1986-10-08
NL190268C (nl) 1994-01-03
FR2487199A1 (fr) 1982-01-29
AR227194A1 (es) 1982-09-30
DK155500B (da) 1989-04-17
DE3127318A1 (de) 1982-04-15
NO157245C (no) 1988-02-24
IT8123070A0 (it) 1981-07-22
FI812295L (fi) 1982-01-23
NL8103329A (nl) 1982-02-16

Similar Documents

Publication Publication Date Title
FI77048B (fi) Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner.
KR860002567A (ko) 혈액응고 억제 단백질의 제조방법
DE3263450D1 (en) Process for the purification of blood coagulation factors ii, vii, ix and/or x and preparations manufactured accordingly
EP0225867A3 (en) Adsorbent and process for preparing the same
NO166943C (no) Analogifremgangsmaate for fremstilling av enzymresistente immunomodulerende peptider.
FI892006A0 (fi) Lactalbumin saosom tillaeggsaemne i mat.
DK97189A (da) Immobiliseringsproces
ATE6163T1 (de) Herstellung von isomaltulose.
EP0214879A3 (en) Process for sulfating glycosaminoglycanes, glycosaminoglycanes obtained and their biological applications
DE3680130D1 (de) Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.
AU7795081A (en) Production of stable blood clotting factors ix + x by warming with calcium ions
AU546588B2 (en) Treating red blood cells to effect sphering and reagent therefore
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
EP0325225A3 (en) Concentrates of coagulation factors ii, vii, ix and/or x, their preparation and use, and method for the determination of coagulation factor vii
PT91953A (pt) Processo para a preparacao de solucoes de antigenes contendo hidroxido de zinco ou hidroxido de ferro como agente auxiliar
ATE17262T1 (de) Verfahren zur quantitativen bestimmung von blutgerinnungsfaktor xii in humanplasma.
FR2491334B1 (fi)
DK241684A (da) Fremgangsmaade til fremstilling af et antithrombin iii-heparin- eller antithrombin iii-heparinoidkoncentrat
DE3381624D1 (de) Mittel zur behandlung von wunden.
DE58907555D1 (de) Verfahren zur Anreicherung der Blutgerinnungsfaktoren II, VII, IX und X.
DK596783A (da) Fremgangsmaade til bestemmelse af blods eller et blodderivats evne til at koagulere og reagens til brug herved
EP0317085A3 (en) Processed red blood cells and process for producing the same
ATE37611T1 (de) Verfahren zur verringerung einer truebung in kontrollseren.
ATE2049T1 (de) Mittel zur therapie von immunkomplexerkrankungen.
KR870700283A (ko) 온실 및 다른 차폐실의 대기를 처리하는 방법과 그 방법을 수행하기 위한 장치

Legal Events

Date Code Title Description
MA Patent expired

Owner name: "IMMUNO" AKTIENGESELLSCHAFT FUER